-
1
-
-
0029860663
-
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: Investigation using 510(k) review criteria, recommended by the Food and Drug Administration
-
Biedenbach DJ, Jones RN (1996) Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: Investigation using 510(k) review criteria, recommended by the Food and Drug Administration. J Clin Microbiol 34:3214-3217.
-
(1996)
J Clin Microbiol
, vol.34
, pp. 3214-3217
-
-
Biedenbach, D.J.1
Jones, R.N.2
-
2
-
-
0029740669
-
Rapid detection of point mutations of the Neisseria gonorrhoeae gyr A gene associated with decreased susceptibilities to quinolones
-
Deguchi T, Yasuda M, Nakano M, Ozeki S, Ezaki T, Maeda SI, Saito I, Kawada Y (1996) Rapid detection of point mutations of the Neisseria gonorrhoeae gyr A gene associated with decreased susceptibilities to quinolones. J Clin Microbiol 34:2255-2258.
-
(1996)
J Clin Microbiol
, vol.34
, pp. 2255-2258
-
-
Deguchi, T.1
Yasuda, M.2
Nakano, M.3
Ozeki, S.4
Ezaki, T.5
Maeda, S.I.6
Saito, I.7
Kawada, Y.8
-
3
-
-
0030911910
-
Rapid screening of point mutations of the Neisseria gonorrhoeae par C gene associated with resistance to quinolones
-
Deguchi T, Yasuda M, Nakano M, Kanematsu E, Ozeki S, Nishino Y, Ezaki T, Maeda SI, Saito I, Kawada Y (1997) Rapid screening of point mutations of the Neisseria gonorrhoeae par C gene associated with resistance to quinolones. J Clin Microbiol 35:948-950.
-
(1997)
J Clin Microbiol
, vol.35
, pp. 948-950
-
-
Deguchi, T.1
Yasuda, M.2
Nakano, M.3
Kanematsu, E.4
Ozeki, S.5
Nishino, Y.6
Ezaki, T.7
Maeda, S.I.8
Saito, I.9
Kawada, Y.10
-
4
-
-
0031879199
-
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aurens
-
Fukuda H, Hori S, Hiramatsu K (1998) Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aurens. Antimicrob Agents Chemother 42:1917-1922.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 1917-1922
-
-
Fukuda, H.1
Hori, S.2
Hiramatsu, K.3
-
5
-
-
0026658475
-
In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8methoxy quinolone
-
Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K (1992) In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8methoxy quinolone. Antimicrob Agents Chemother 36:2108-2117.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 2108-2117
-
-
Hosaka, M.1
Yasue, T.2
Fukuda, H.3
Tomizawa, H.4
Aoyama, H.5
Hirai, K.6
-
6
-
-
0030867393
-
Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae, interpretive criteria and comparisons with Etest results
-
Jones RN, Barrett MS, Deguchi T (1997) Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae, interpretive criteria and comparisons with Etest results. Diagn Microbiol Infect Dis 28:193-200.
-
(1997)
Diagn Microbiol Infect Dis
, vol.28
, pp. 193-200
-
-
Jones, R.N.1
Barrett, M.S.2
Deguchi, T.3
-
8
-
-
0028088075
-
Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993
-
Knapp JS, Washington JA, Doyle LJ, Neal SW, Parekh MC, Rice RJ (1994) Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother 38:2194-2196.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 2194-2196
-
-
Knapp, J.S.1
Washington, J.A.2
Doyle, L.J.3
Neal, S.W.4
Parekh, M.C.5
Rice, R.J.6
-
9
-
-
0028940924
-
Drugs of choice for the treatment of uncomplicated gonoccal infections
-
Moran JS, Levine WC (1995) Drugs of choice for the treatment of uncomplicated gonoccal infections. Clin Infect Dis 20(suppl 1);S47-S65.
-
(1995)
Clin Infect Dis
, vol.20
, Issue.SUPPL. 1
-
-
Moran, J.S.1
Levine, W.C.2
-
12
-
-
0013472644
-
Performance standards for antimicrobial susceptibility testing
-
Wayne, PA: NCCLS
-
National Committee for Clinical Laboratory Standards (1998) Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S8. Wayne, PA: NCCLS.
-
(1998)
Supplemental Tables, M100-S8
-
-
-
13
-
-
0029080736
-
Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan
-
Tanaka M, Matsumoto T, Kobayashi I, Uchino U, Kumazawa J (1995) Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob Agents Chemother 39:2367-2370.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2367-2370
-
-
Tanaka, M.1
Matsumoto, T.2
Kobayashi, I.3
Uchino, U.4
Kumazawa, J.5
-
14
-
-
0029911379
-
Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro
-
Tankovic J, Perichon B, Duval J, Courvalin P (1996) Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob Agents Chemother 40:2505-2510.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2505-2510
-
-
Tankovic, J.1
Perichon, B.2
Duval, J.3
Courvalin, P.4
-
15
-
-
0026595055
-
Failure of 500 mg of ciprofloxacin therapy in male urethral gonorrhoeae
-
Tapsall JW, Lovett R, Munro R (1992) Failure of 500 mg of ciprofloxacin therapy in male urethral gonorrhoeae. Med J Aust 156:143.
-
(1992)
Med J Aust
, vol.156
, pp. 143
-
-
Tapsall, J.W.1
Lovett, R.2
Munro, R.3
|